Table 2

Prevalence of STI/HIV in 598 men and women in Alto Rio Solimões, Amazonas state, Brazil, by sex

STI/HIVMen (N=285)Women (N=313)p Value*Total (N=598)
n (%)n (%)% (95% CI)
Neisseria gonorrhoeae3 (1.1)1 (0.3)0.270.7 (0.2 to 1.7)
Chlamydia trachomatis4 (1.4)15 (4.8)0.023.2 (1.9 to 4.9)
High-risk HPV41 (14.4)75 (24.0)0.00319.4 (16.3 to 22.8)
Syphilis exposure (FTA-ABs+)10 (3.6)8 (2.6)0.513.1 (1.8 to 4.8)
Active syphilis (FTA-ABs+/VDRL+)§9 (3.2)8 (2.6)0.702.8 (1.7 to 4.5)
Serological HSV-2143 (51.1)220 (72.1)<0.00162.1 (58.0 to 66.0)
Serological HBV (anti-HBc)106 (37.9)130 (42.6)0.2440.3 (36.3 to 44.4)
Serological HBV (HBsAg)**21 (7.5)14 (4.6)0.145.9 (4.0 to 7.9)
Serological HCV2 (0.7)2 (0.7)0.900.7 (0.2 to 1.7)
Serological HIV4 (1.4)0 (0.0)0.040.7 (0.2 to 1.7)
  • * Using Pearson χ2 test unless specified.

  • Fisher's exact test.

  • FTA-ABs with a positive result.

  • § FTA-ABs with a positive result confirmed by VDRL.

  • Markers of chronic HBV infection.

  • ** Markers of active HBV infection.

  • FTA-ABs, fluorescent treponemal antibody absorption; HBV, hepatitis B virus; HCV, hepatitis C virus; HPV, human papillomavirus; HSV-2, herpes simplex virus type-2; STI, sexually transmitted infection; VDRL, Venereal Diseases Research Laboratory.

  • Bold values indicate statistical significance (p<0.05).